4.8 Article

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Virology

Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects

Elena Criscuolo et al.

Summary: This study compared two serologic tests for SARS-CoV-2, showing an increase in sensitivity over time and high specificity. However, a poor direct correlation between antibody levels and neutralizing activity was observed. These findings highlight the importance of further research on antibody kinetics and the role of neutralizing antibodies for the development of effective vaccines.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Immunology

Viral Cultures for Coronavirus Disease 2019 Infectivity Assessment: A Systematic Review

Tom Jefferson et al.

Summary: This review aimed to investigate the relationship between SARS-CoV-2 culture and RT-PCR results, as well as other variables such as time from symptom onset. The findings suggest that there is a correlation between Ct values, symptom severity, and the ability to culture live virus. It was also noted that those with high Ct values are less likely to have infectious potential.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Medicine, General & Internal

Correlates of protection from SARS-CoV-2 infection

Florian Krammer

LANCET (2021)

Article Medicine, General & Internal

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas et al.

Summary: This study assessed the real-world effectiveness of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 in Israel, showing high efficacy in preventing SARS-CoV-2 infections, hospitalizations, severe disease, and death. As vaccine coverage increased, there were marked declines in SARS-CoV-2 outcomes, indicating that COVID-19 vaccination can help control the pandemic.

LANCET (2021)

Article Medicine, General & Internal

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Victoria Jane Hall et al.

Summary: This study investigated whether antibodies against SARS-CoV-2 were associated with a decreased risk of symptomatic and asymptomatic reinfection. It found that individuals with a previous history of SARS-CoV-2 infection had an 84% lower risk of reinfection, with a median protective effect lasting for 7 months following primary infection.

LANCET (2021)

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Ezgi Hacisuleyman et al.

Summary: Despite evidence of vaccine efficacy, two fully vaccinated individuals developed mild symptoms of Covid-19 and were infected with variants of SARS-CoV-2. Sequencing of the virus isolates revealed novel mutations, highlighting the potential risk of illness post-vaccination and subsequent infection with variant virus. Efforts to prevent, diagnose, and characterize variants in vaccinated individuals are crucial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Public, Environmental & Occupational Health

Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021

Corinne N. Thompson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Letter Infectious Diseases

Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India

J. Beena Philomina et al.

JOURNAL OF INFECTION (2021)

Article Biochemistry & Molecular Biology

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

Talia Kustin et al.

Summary: Breakthrough SARS-CoV-2 infections post-vaccination may be caused by B.1.1.7 or B.1.351 variants, indicating the importance of robust vaccination. Reduced vaccine effectiveness against these variants was observed in the study, highlighting the need for continued surveillance and enhanced vaccination efforts.

NATURE MEDICINE (2021)

Article Immunology

Evidence for antibody as a protective correlate for COVID-19 vaccines

Kristen A. Earle et al.

Summary: The study found a strong correlation between antibody titers and efficacy when assessing different COVID-19 vaccines, supporting the use of post-immunization antibody titers as the basis for establishing a correlate of protection for COVID-19 vaccines.

VACCINE (2021)

Article Health Care Sciences & Services

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel

Gili Regev-Yochay et al.

Summary: The study found that the BNT162b2 vaccine is moderately to highly effective in reducing infectivity by preventing infection and reducing viral shedding.

LANCET REGIONAL HEALTH-EUROPE (2021)